ReviewCancer drug resistance (Alhambra, Calif.)2019
PARP inhibitors: clinical development, emerging differences, and the current therapeutic issues.
Pooja Murthy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
30 papers cite it
this paperpooled ittrialcites it